SightfileU.S. market data from official filings

Companies › BOLT

Bolt Biotherapeutics Inc (BOLT)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001641281 · EDGAR filings · Updated 2026-06-11

Bolt Biotherapeutics Inc (BOLT) has reported institutional ownership of 31.9%, with 24 institutional managers holding positions valued at $2.49M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
31.9%
Institutional managers
24
Reported 13F value
$2.49M
Insider activity
11 trans.
$8.22K net buying
Data flags
2 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Bolt Biotherapeutics Inc has 24 institutional holders and institutional ownership of 31.9%.

Insider activity

Insiders reported 11 transactions (8 buys, 0 sells) across 3 reporting insiders, with a net reported value of $8.22K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-12 (recurring since 2025-03-24) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2025-01-03 (recurring since 2024-07-03) — source filing. The authoritative details are those stated in the filing itself.

Related companies

Lantern Pharma Inc (LTRN) · SERINA THERAPEUTICS INC (SER) · ONCOLYTICS BIOTECH INC COM NEW (ONCY) · BIOATLA INC (BCAB) · CEL SCI Corp (CVM) · LONGEVERON INC (LGVN)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-11.